The Advisory Committee on Immunization Practices (ACIP) issued recommendations for the use of acellular pertussis vaccines. The text describes the licensing and recommended administration schedules for DTaP vaccines like Tripedia, ACEL-IMUNE, and Infanrix for children aged 6 weeks to 6 years. It is sourced from the paperswithcode platform.
Use Cases
- Analyzing the evolution of vaccine recommendations based on safety and efficacy data mentioned in the description
- Studying the licensing timeline and approved uses for specific DTaP vaccines like Tripedia and Infanrix
- Comparing recommendations for acellular versus whole-cell pertussis vaccines as detailed in the text
Strengths
- Provides specific vaccine names and licensing dates, such as Infanrix in January 1997
- Details precise age groups for vaccine administration, including children aged 6 weeks to 6 years
Limitations
- Row count is unknown, which may limit suitability assessment
- Column-level documentation is absent; field semantics must be inferred after download
- Last update date is unknown; freshness unverified
Provenance
- Source
- Advisory Committee on Immunization Practices (ACIP)
- Collection Method
- Public health recommendations and guidelines